-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.
-
Summary
-
Anbio Biotechnology quarterly Liabilities and Equity history and change rate from Q4 2023 to Q4 2024.
- Anbio Biotechnology Liabilities and Equity for the quarter ending 31 Dec 2024 was $18.9M, a 19.7% increase year-over-year.
Liabilities and Equity, Quarterly (USD)
Liabilities and Equity, YoY Quarterly Change (%)